Lawrence M. Alleva, Director at Adaptimmune Therapeutics PLC (ADAP), bought 47,280 shares at $0.84 ($40K) on 2018-12-17, disclosed to the SEC on 2018-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADAP | BUY | 2021-06-03 | $10K | — | Filing → |
| MRSN | BUY | 2021-06-03 | $15K | — | Filing → |
| GRTX | BUY | 2020-11-17 | $24K | — | Filing → |